Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial | |
Ren, Hong; Li, Xiao; Ni, Zhao-Hui; Niu, Jian-Ying; Cao, Bin; Xu, Jie; Cheng, Hong; Tu, Xiao-Wen; Ren, Ai-Min; Hu, Ying | |
刊名 | INTERNATIONAL UROLOGY AND NEPHROLOGY |
2017 | |
卷号 | 49期号:3 |
关键词 | Levofloxacin Complicated urinary tract infection (cUTI) Acute pyelonephritis (APN) Noninferiority trial |
ISSN号 | 0301-1623 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3617296 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Ren, Hong,Li, Xiao,Ni, Zhao-Hui,et al. Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial[J]. INTERNATIONAL UROLOGY AND NEPHROLOGY,2017,49(3). |
APA | Ren, Hong.,Li, Xiao.,Ni, Zhao-Hui.,Niu, Jian-Ying.,Cao, Bin.,...&Chen, Nan.(2017).Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial.INTERNATIONAL UROLOGY AND NEPHROLOGY,49(3). |
MLA | Ren, Hong,et al."Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial".INTERNATIONAL UROLOGY AND NEPHROLOGY 49.3(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论